Stephens analyst Scott Fidel raised the firm’s price target on Pennant Group to $32 from $28 and keeps an Overweight rating on the shares. Pennant “continues to execute on all key themes we highlighted” and execution on M&A should allow the company to deliver 28% revenue growth in 2024, the analyst tells investors in a post-Q2 note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PNTG:
- Pennant Group sees FY24 adjusted EPS 89c-95c, consensus 89c
- Pennant Group reports Q2 adjusted EPS 24c, consensus 21c
- Pennant Group files automatic mixed securities shelf
- Pennant Group Enhances Investor Relations with Presentation Update
- Pennant Completes Acquisition of Signature Healthcare at Home’s Washington and Idaho Assets
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue